EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson’s Disease

Jun Shen, Shasha Chen, Xin Li, Lele Wu, Xue Mao, Jingjie Jiang, Dabu Zhu

Neurochemical Research · 2024-05 · 49 (5) · 1291-1305

DOI: 10.1007/s11064-024-04116-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 29.02.2024. Verfasst von Jun Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Hangzhou Linping District First People's Hospital, No. 369 Yingbin Road, Nanyuan Street, Linping District, Hangzhou, …. Hauptthemen laut MEDLINE: Parkinson Disease, Ferroptosis, Neuroblastoma, Glucosides. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, The Medical and Health Technology Project of Linping District.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s Disease (PD) is characterized by the loss of dopaminergic neurons, with ferroptosis playing a significant role. Salidroside (SAL) has shown neuroprotective potential, this study aims to explore its capacity to mitigate ferroptosis in PD, focusing on the modulation of the Nuclear Factor E2-Related Factor 2 (Nrf2)/ Glutathione Peroxidase 4 (GPX4) pathway. Male C57BL/6 mice were subjected to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to induce PD-like symptoms, followed by SAL and Nrf2 inhibitor administration. Then behavioral tests, immunohistochemical staining, transmission electron microscopy, and Western blot analysis were conducted to assess motor functions, pathological changes, ferroptosis, and related protein expressions. In vitro, SH-SY5Y cells were treated with erastin to induce ferroptosis to assess the protective effects of SAL. Additionally, A53T-α-synuclein (α-syn) was used to stimulate the PD model, SAL and a Nrf2 inhibitor (ML385) was utilized to elucidate the role of the Nrf2/GPX4 pathway in mitigating ferroptosis in PD. In vivo , SAL significantly improved motor functions and reduced the expression of α-syn, while increasing tyrosine hydroxylase (TH) expression of PD mice. Additionally, SAL treatment notably enhanced the levels of antioxidants and reduced MDA and iron content in the substantia nigra of PD mice. In vitro , SAL treatment increased the TH, GPX4, Nrf2 expression, and mitochondrial membrane potential whereas alleviated ferroptosis through the Nrf2/GPX4 pathway, as evidenced in erastin-induced and α-syn overexpressing SH-SY5Y cells. While these effects were reversed upon Nrf2 inhibition. SAL demonstrates significant potential in mitigating PD pathology and ferroptosis, positioning the Nrf2/GPX4 pathway as a promising therapeutic target. However, future studies should focus on the long-term effects of SAL, its pharmacokinetics, addressing the multifactorial nature of PD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseFerroptosisNeuroblastomaGlucosidesPhenolsMaleHumansMiceAnimalsNF-E2-Related Factor 2Signal TransductionMice, Inbred C57BL

Stichwörter der Autor:innen

FerroptosisNrf2/GPX4Parkinson’s diseaseSalidroside

Substanzen

rhodiolosideNF-E2-Related Factor 2GlucosidesPhenols

Autor:innen und Institutionen

  • Department of General Medicine, Hangzhou Linping District First People's Hospital, No. 369 Yingbin Road, Nanyuan Street, Linping District, Hangzhou, 311199, Zhejiang, China. shenjunlinping@163.com.
  • Department of Medical Geriatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
  • Department of General Medicine, Hangzhou Linping District First People's Hospital, No. 369 Yingbin Road, Nanyuan Street, Linping District, Hangzhou, 311199, Zhejiang, China.
  • Department of Pharmacy, Hangzhou Linping District First People's Hospital, Hangzhou, 311199, Zhejiang, China.

Förderung

  • Wellcome Trust
  • The Medical and Health Technology Project of Linping District

Zitieren

APA

Shen, J., Chen, S., Li, X., Wu, L., Mao, X., Jiang, J., & Zhu, D. (2024). Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson’s Disease. Neurochemical Research, 49(5), 1291-1305. https://doi.org/10.1007/s11064-024-04116-w

Vancouver

Shen J, Chen S, Li X, Wu L, Mao X, Jiang J, et al. Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson’s Disease. Neurochemical Research. 2024;49(5):1291-1305. doi:10.1007/s11064-024-04116-w

BibTeX
@article{Shen2024,
  author = {Shen, Jun and Chen, Shasha and Li, Xin and Wu, Lele and Mao, Xue and Jiang, Jingjie and Zhu, Dabu},
  title = {Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson’s Disease},
  journal = {Neurochemical Research},
  year = {2024},
  volume = {49},
  number = {5},
  pages = {1291--1305},
  doi = {10.1007/s11064-024-04116-w}
}
Kostenlos starten →